Physical Activity Stress and Sleep in Adolescents
NCT04187885, Not applicable, Unknown, Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Physical Activity Stress and Sleep in Adolescents | ClinicalTrials.gov |
| NCT number | NCT04187885 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 56 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose | ClinicalTrials.gov |
| Conditions | Adolescent Problem Behavior | ClinicalTrials.gov |
| Interventions | Group/Cohort 2: PAP | ClinicalTrials.gov |
| First posted | 2019-12-05 | ClinicalTrials.gov |
| Last updated | 2019-12-05 | ClinicalTrials.gov |
Registered outcomes 19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | sleep Efficiency (%) | change from baseline at 4th night | the percentage of time spent asleep while in bed | ClinicalTrials.gov |
| Secondary | bedtime | change from baseline at 4th night | the time when the subjet goes to bed | ClinicalTrials.gov |
| Secondary | total time in bed (minutes) | change from baseline at 4th night | total time spent in bed | ClinicalTrials.gov |
| Secondary | sleep onset latency (minutes) | change from baseline at 4th night | actual time it takes to transition from wake to sleep in minutes | ClinicalTrials.gov |
| Secondary | wake after sleep onset | change from baseline at 4th night | awke after sleep has been initiated and before final awake | ClinicalTrials.gov |
| Secondary | nubmer of awake >3 minutes | change from baseline at 4th night | awkenings \>3 minutes after sleep has been initiated and before final awake | ClinicalTrials.gov |
| Secondary | Sedentary activities | pre and post intervention:day 1 and day 4 | time spent on Sedentary activities \< 1Metabolic Equivalent of task (METs), | ClinicalTrials.gov |
| Secondary | light activities | pre and post intervention:day 1 and day 4 | time spent on \[1 - 3 \] expressed in Metabolic equivalent of task (METs) | ClinicalTrials.gov |
| Secondary | moderate to vigorous activities | pre and post intervention : day1 and day 4 | time spent on moderate to vigorous activities \[3 - 9 Metabolic equivalent of task\[ | ClinicalTrials.gov |
| Secondary | Energy expenditure (kilo calories) | pre and post intervention : day1 and day 4 | the amount of energy a person uses in the form of calories estimated by accelerometers | ClinicalTrials.gov |
| Secondary | circadian phase (DLMO) | night 4 | evaluations of melatonin peak from salivary specimens (5 measures), time (180, 120, 60 min before bedtime, bedtime and 60 min after bedtime) | ClinicalTrials.gov |
| Secondary | Cortisol peak | day 5 | evaluations of cortisol peak from salivary specimens (5 measures), (upon awakening, awakening + 30mn, awakening + 60mn, awakening + 120mn et awakening + 180mn) | ClinicalTrials.gov |
| Secondary | Stroop test | day 5 | selective attention and reading ability | ClinicalTrials.gov |
| Secondary | Trail marking test | day 5 | this test estimate visual attention and motor speed | ClinicalTrials.gov |
| Secondary | Barrage test | day 5 | this task evaluates visual- spatial ability and recognition | ClinicalTrials.gov |
| Secondary | California verbal learning test. | day 5 | this test evaluates primary and secondary memory | ClinicalTrials.gov |
| Secondary | Energy intake | day 5 | Energy intake and proportion of the energy derived from each class of macronutrients (carbohydrate, fat, and protein) measured on meals offered "ad-libitum" | ClinicalTrials.gov |
| Secondary | Subjective appetite sensations | day 5 | hunger, fullness, desire to eat and prospective food consumption : upon awakening, before and right after the breakfast, lunch, snack and dinner as well as bed time. Appetite sensations will be collected throughout the day using visual analogue scales (150 mm scales). Adolescents will report their hunger, fullness, desire to eat and prospective food consumption at thirteen regulated times: upon awakening, before and right after the breakfast, lunch, snack and dinner as well as bed time. The questions were i) "How hungry do you feel?", ii) "How full do you feel?", iii) "Would you like to eat something?", iv) "How much do you think you can eat?" (adolescents were asked to respond on a scale from "not at all" to "a lot"). This method has been previously validated | ClinicalTrials.gov |
| Secondary | Subjective sleepiness (Karolinska scale) | day 5 | this scale mesures the subjective level os sleepness at particular times during the day. this is a nine point scale (1= extreemly alert, 3= alert, 5= neither nor sleepy, 7 = sleepy but no difficulty for main awake, 9= extreemly sleepy/ fighting sleep). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 11
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)